Company intelligence / Profile preview

Agno Pharmaceuticals

Bethlehem, Pennsylvania, United Statesagnopharma.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Agno Pharmaceuticals is an established US-based global CDMO specializing in small molecule process development and cGMP manufacturing. The company offers end-to-end services from regulatory starting materials to complex drug product formulation—including highly potent compounds and sterile injectables. It has a strong track record with over 400 projects delivered since 2004 and recently expanded capabilities through the acquisition of Particle Sciences for advanced formulation technologies.

Modalities: Small moleculeSterile injectableDrug-eluting deviceAPIHighly potent APISterile APIComplex injectableImplant
Industry: Contract Manufacturing Organization

Partnerships

Vivo CapitalBain Capital

Beyond the preview

Go deeper on Agno Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agno Pharmaceuticals.

Explore the full profile